Antiretroviral therapy adherence among people living with HIV in Vietnam using a multi-method tool: A cross-sectional study

Abstract

Objective: To assess antiretroviral therapy (ART) adherence rates and associated factors among people living with HIV in Vietnam.

Methods: A cross-sectional study was conducted at the Hospital for Tropical Diseases, Ho Chi Minh City from June to August 2022. Data were collected from 347 people living with HIV using structured questionnaires assessing sociodemographics, substance use, drug side effects, treatment beliefs, treatment satisfaction, and depression. ART adherence was evaluated using a multi-method tool, including selfreport, pill count, the Provider Interview Tool, and the Visual Analog Scale. Participants were classified as having high adherence only if they met all four criteria across these methods. Multivariable logistic regression was used to identify factors influencing adherence, with significance set at P<0.05.

Results High ART adherence was observed in 69.5% of the participants. Adherence was significantly lower among tobacco users (OR 0.49, 95% Cl 0.30-0.83, P=0.007), those with higher depression scores (per 1-point increase) (OR 0.89, 95% Cl 0.84-0.95, P<0.001), frequent substance users (OR 0.50, 95% Cl 0.30-0.83, P=0.007), and those experiencing more severe drug side effects (per level increase) (OR 0.64, 95% Cl 0.45-0.92, P=0.016). Participants able to afford treatment had nearly three times higher odds of adherence than those unable to pay (OR 2.85, 95% Cl 1.48-5.47, P=0.002).

Conclusions:ART adherence among people living with HIV in Vietnam remains suboptimal. Interventions should target substance use, drug side effects, financial barriers, and depression screening to improve adherence.

Keywords

HIV / Antiretroviral therapy adherence / Tobacco / Side effects / Substance use / Depression / Treatment costs

Conflict of interest statement

The authors declare that there is no conflict of interest.

Acknowledgments

We wish to acknowledge the support of the leaders at the Hospital for Tropical Diseases who facilitated the study. We thank all the participants for the time and effort that they devoted to the study.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors’ contributions

All authors contributed substantially to drafting, revising, and approving the article's final version. LTV and GH contributed to the conception and design of the study and acquisition of the data. DQP, BVKQ, and LTV cleared and analyzed the data. DPQ, AG, HTNN, HTMN, LYV, and GH were the contributors to the interpretation of the data.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] World Health Organization. HIV and AIDS 2024.[Online]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. [Accessed on 22 July 2024].

[2] World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. 2022. [Online]. Available from: https://www.who.int/publications/i/item/9789240053779. [Accessed on 22 July 2024].

[3] The Joint United Nations Program on HIV/AIDS (UNAIDS). Countries profile 2023. [Online]. Available from: https://www.unaids.org/en/regionscountries/countries. [Accessed on 31 Decmber 2024].

[4] Vietnam Ministry of Health. Plan for HIV/AIDS prevention and control in 2024. Hanoi, Vietnam; 2024. Report No.: 612. [Online]. Available from: https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-612-QD-BYT-2024-Ke-hoach-phong-chong-HIV-AIDS-602110.aspx. [Accessed on 22 July 2024].Accessed on 22 July 2024].

[5] Vo LT, Phan DQ, Nguyen PH, Gyan A, Vuong NM, Nguyen TNL, et al. Clinical characteristics and treatment outcomes of opportunistic infections in advanced HIV disease patients among men who have sex with men in Vietnam: A prospective cross-sectional study. BMC Infect Dis 2025; 25(1): 271.

[6] Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: Comparisons with general population. Curr Opin HIV AIDS 2016; 11(5): 492-500.

[7] Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. JAIDS 2006; 41(3): 285-297.

[8] Senu E, Sakyi SA, Ayisi-Boateng NK, Enimil AK, Opoku S, Ansah RO, et al. Factors associated with anti-retroviral therapy (ART) adherence among adult people living with HIV (PLWH): A 5-year retrospective multi-centre study in Kumasi, Ghana. Dialogues Health 2022; 1: 100082.

[9] Chakraborty A, Hershow RC, Qato DM, Stayner L, Dworkin MS. Adherence to antiretroviral therapy among HIV patients in India: A systematic review and meta-analysis. AIDS Behav 2020; 24: 2130-2148.

[10] Wang YY, Jin Y, Chen C, Zheng W, Wang SB, Ungvari GS, et al. Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China. AIDS Care 2019; 31(8): 913-922.

[11] McComsey GA, Lingohr-Smith M, Rogers R, Lin J, Donga P. Real-world adherence to antiretroviral therapy among HIV-1 patients across the United States. Adv Ther 2021; 38(9): 4961-4974.

[12] Neupane S, Dhungana GP, Ghimire HC. Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal. BMC Public Health 2019; 19: 1-9.

[13] Tuot S, Sim JW, Nagashima-Hayashi M, Chhoun P, Teo AKJ, Prem K, et al. What are the determinants of antiretroviral therapy adherence among stable people living with HIV? A cross-sectional study in Cambodia. AIDS Res Ther 2023; 20(1): 47.

[14] Nguyen PM, Thach AN, Pham XD, Lam AN, Nguyen TN, Duong CX, et al. Prevalence and determinants of medication adherence among patients with HIV/AIDS in southern Vietnam. Infect Dis Rep 2021; 13(1): 126-135.

[15] Le PM, Nguyen PT, Nguyen HV, Bui DH, Vo SH, Nguyen NV, et al. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam. Int J STD AIDS 2021; 32(10): 911-918.

[16] Mai HT, Le GM, Tran BX, Do HN, Latkin CA, Nguyen LT, et al. Adherence to antiretroviral therapy among HIV/AIDS patients in the context of early treatment initiation in Vietnam. Patient Prefer Adherence 2018; 12: 2131-2137.

[17] Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat 2012; 2012(1): 574656.

[18] Boadu I, Manu A, Aryeetey RNO, Kesse KA, Abdulai M, Acheampong E, et al. Adherence to antiretroviral therapy among HIV patients in Ghana: A systematic review and meta-analysis. PLoS Glob Public Health 2023; 3(11): e0002448.

[19] Iacob SA, Iacob DG, Jugulete G. Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment-clinical points of view and practical considerations. Front Pharmacol 2017; 8: 831.

[20] Armoon B, Fleury MJ, Bayat AH, Fakhri Y, Higgs P, Moghaddam LF, et al. HIV related stigma associated with social support, alcohol use disorders, depression, anxiety, and suicidal ideation among people living with HIV: A systematic review and meta-analysis. Int J Ment Health Syst 2022; 16(1): 17.

[21] Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: An ethnographic study. PLoS Med 2009; 6(1): e1000011.

[22] Da W, Li X, Qiao S, Zhou Y, Shen Z. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China. PLoS One 2018; 13(8): e0203032.

[23] Liao R, Tang Z, Zhang N, Hu L, Chang Z, Ren J, et al. Discrepancies between self-reported medication in adherence and indirect measurement adherence among patients undergoing antiretroviral therapy: A systematic review. Infect Dis Poverty 2024; 13(4): 1-13.

[24] Steel G, Nwokike J, Joshi MP. Development of a multi-method tool to measure ART adherence in resource-constrained settings: The South Africa experience. RPM Plus 2007; 6. [Online]. Available from: https://www.researchgate.net/profile/Jude-Nwokike/publication/267362525_Development_of_a_Multi-Method_Tool_to_Measure_ART_Adherence_in_Resource-Constrained_Settings_The_South_Africa_Experience_Development_of_a_Multi-Method_Tool_to_Measure_ART_Adherence_in_Resource-Constra/links/56ecc44508aed17d09f6784d/Development-of-a-Multi-Method-Tool-to-Measure-ART-Adherence-in-Resource-Constrained-Settings-The-South-Africa-Experience-Development-of-a-Multi-Method-Tool-to-Measure-ART-Adherence-in-Resource-Constra.pdf?__cf_chl_tk=ipZ_pq5bcfcqBjn4q2be7226ZM1opmenZQhV8BXxubs-1743408732-1.0.1.1-WogINj9Q3c0RGA5V0.n6In1HaTYanJ2UGxRpc.tNvYg. [Accessed on 31 Decmber 2024].

[25] Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry 2015; 37(1): 67-75.

[26] Nemoto T, Beglar D, editors. Likert-scale questionnaires. JALT 2013 conference proceedings; 2014. [Online]. Available from: https://jalt-publications.org/sites/default/files/pdf-article/jalt2013_001.pdf. [Accessed on 22 July 2024].

[27] Ngoc TLH, Le MAT, Nguyen HT, Vo HV, Le NQ, Tang LNP, et al. Patient Health Questionnaire (PHQ-9): A depression screening tool for people with epilepsy in Vietnam. Epilepsy Behav 2021; 125: 108446.

[28] STATA. Stata Statistical Software: Release 17 2021. StataCorp. [Online]. Available from: https://www.stata.com/stata17/. [Accessed on 22 July 2024].

[29] Mbonye M, Seeley J, Ssembajja F, Birungi J, Jaffar S. Adherence to antiretroviral therapy in Jinja, Uganda: A six-year follow-up study. PLoS One 2013; 8(10): e78243.

[30] Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS 2012; 26(8): 479-485.

[31] Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein- Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: A systematic review. BMJ Glob Health 2016; 1(4): e000125.

[32] Kumar SR, Swaminathan S, Flanigan T, Mayer K, Niaura R. HIV & smoking in India. IJMR 2009; 130(1): 15-22.

[33] Carrico AW, Hunt PW, Neilands TB, Dilworth SE, Martin JN, Deeks SG, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. JAIDS 2019; 80(1): 89-93.

[34] Liu J, Yan Y, Li Y, Lin K, Xie Y, Tan Z, et al. Factors associated with antiretroviral treatment adherence among people living with HIV in Guangdong Province, China: A cross sectional analysis. BMC Public Health 2024; 24(1): 1358.

[35] Alvi Y, Khalique N, Ahmad A, Sameen S. A study on side effect of antiretroviral therapy among people living with HIV/AIDS. JPDS 2019; 16(1): 22-25.

[36] Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: A cross sectional study. BMC Pharmacol Toxicol 2014; 15: 1-9.

[37] Anastasiades MH, Gupton O, Fritz A, Caldaza P, Stillman M. Diabetes, depression and nonadherence: Exploring hopelessness as a meditating factor: A preliminary study. Ment Health Fam Med 2016; 12: 243-249.

[38] Mohamud AK, Ahmed OA, Mohamud AA, Dirie NI. Prevalence of and factors associated with depression among adult patients living with HIV/AIDs undergoing ART unit in Banadir hospital, Mogadishu Somalia. BMC Psychiatry 2023; 23(1): 232.

[39] Thai TT, Jones MK, Harris LM, Heard RC, Hills NK, Lindan CP. Symptoms of depression in people living with HIV in Ho Chi Minh City, Vietnam: Prevalence and associated factors. AIDS Behav 2018; 22: 76-84.